Publications

Find coverage of the latest original articles on Lupus, focusing on those with data on therapeutic interventions and those that have clinical impact.

This activity is supported by an educational grant from AstraZeneca.

Literature Highlights

Publications

Clear Search

Showing 1 result for “SLE-BRAVE-II” published 2023.

March 2023
Publication thumbnail: Baricitinib for Systemic Lupus Erythematosus: a Double-blind, Randomised, Placebo-controlled, Phase 3 trial (SLE-BRAVE-II) View Slides

Baricitinib for Systemic Lupus Erythematosus: a Double-blind, Randomised, Placebo-controlled, Phase 3 trial (SLE-BRAVE-II)

, , , , , , , , , , , , , ,

Lancet. 2023 doi: 10.1016/S0140-6736(22)02546-6

Negative results of SLE-BRAVE-II trial show that evidence for the efficacy of baricitinib in SLE is inconclusive.

more…

Keywords: